Glycemic control in non-diabetic critically ill patients.
暂无分享,去创建一个
[1] Limin Peng,et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) , 2011, Diabetes Care.
[2] B. Kavanagh,et al. Clinical practice. Glycemic control in the ICU. , 2010, The New England journal of medicine.
[3] Mark Woodward,et al. Severe hypoglycemia and risks of vascular events and death. , 2010, The New England journal of medicine.
[4] J. Preiser,et al. International recommendations for glucose control in adult non diabetic critically ill patients , 2010, Critical care.
[5] S. Hailpern,et al. Prevalence of hemoglobin A1c greater than 6.5% and 7.0% among hospitalized patients without known diagnosis of diabetes at an urban inner city hospital. , 2010, The Journal of clinical endocrinology and metabolism.
[6] Harald Herkner,et al. Real-Time Continuous Glucose Monitoring in Critically Ill Patients , 2009, Diabetes Care.
[7] Mercedes Falciglia,et al. Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis* , 2009, Critical care medicine.
[8] C. Cook,et al. Inpatient glucose control: a glycemic survey of 126 U.S. hospitals. , 2009, Journal of hospital medicine.
[9] E. Barrett-Connor,et al. A1C and Diabetes Diagnosis: The Rancho Bernardo Study , 2009, Diabetes Care.
[10] A. Donihi,et al. Implementation of standardized instructions for insulin at hospital discharge. , 2009, Journal of hospital medicine.
[11] Johan Groeneveld,et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study , 2009, Intensive Care Medicine.
[12] O. Tanner. Intensive versus Conventional Glucose Control in Critically Ill Patients , 2009 .
[13] J. Shaw,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[14] Richard Hellman,et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[15] H. Krumholz,et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. , 2009, JAMA.
[16] Deborah J. Cook,et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.
[17] H. Krumholz,et al. Elevated Admission Glucose and Mortality in Elderly Patients Hospitalized With Heart Failure , 2009, Circulation.
[18] C. Cook,et al. Inpatient to outpatient transfer of diabetes care: planing for an effective hospital discharge. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[19] Limin Peng,et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.
[20] J. Donado,et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial , 2008, Critical care.
[21] A. Amin,et al. Bridge over troubled waters: safe and effective transitions of the inpatient with hyperglycemia. , 2008, Journal of hospital medicine.
[22] S. Inzucchi,et al. Subcutaneous insulin order sets and protocols: effective design and implementation strategies. , 2008, Journal of hospital medicine.
[23] J. Preiser,et al. Tight glucose control and hypoglycemia. , 2008, Critical care medicine.
[24] R. MacIsaac,et al. Outcomes for general medical inpatients with diabetes mellitus and new hyperglycaemia , 2008, The Medical journal of Australia.
[25] T. Donner,et al. Diabetes management in the hospital. , 2008, The Medical clinics of North America.
[26] Rolf Rossaint,et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.
[27] D. Reeds,et al. A pilot study to evaluate the effectiveness of glargine and multiple injections of lispro in patients with type 2 diabetes receiving tube feedings in a cardiovascular intensive care unit. , 2007, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[28] H. Rodbard,et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[29] Yingxing Wu,et al. Eliminating the diabetic disadvantage: the Portland Diabetic Project. , 2006, Seminars in thoracic and cardiovascular surgery.
[30] S. Donaldson,et al. Rush University Guidelines and Protocols for the Management of Hyperglycemia in Hospitalized Patients , 2006, The Diabetes educator.
[31] M. Molitch,et al. Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[32] Jaap E Tulleken,et al. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients , 2006, Critical care.
[33] M. Saul,et al. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[34] Yingxing Wu,et al. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[35] G. Van den Berghe,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.
[36] R. Kalyani,et al. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. , 2006, JAMA.
[37] N. Clark,et al. Standards of Medical Care in Diabetes: Response to Power , 2006 .
[38] R. Mcnutt,et al. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. , 2005, Diabetes care.
[39] A. Kitabchi,et al. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. , 2004, Diabetes.
[40] Yingxing Wu,et al. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[41] A. Kitabchi,et al. ICU care for patients with diabetes , 2004 .
[42] I. Hirsch,et al. Erratum: Management of diabetes and hyperglycemia in hospitals (Technical Review) (Diabetes Care (2004) 27 (553-591)) , 2004 .
[43] R. Robertson. Islet transplantation as a treatment for diabetes - a work in progress. , 2004, The New England journal of medicine.
[44] Irl B Hirsch,et al. Management of diabetes and hyperglycemia in hospitals. , 2004, Diabetes care.
[45] James Stephen Krinsley,et al. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. , 2003, Mayo Clinic proceedings.
[46] G. Van den Berghe,et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. , 2003, Endocrinology.
[47] Timothy W. Evans,et al. Glucose Control and Mortality in Critically Ill Patients , 2003 .
[48] Irl B Hirsch,et al. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. , 2003, The Journal of clinical endocrinology and metabolism.
[49] G. Grunkemeier,et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.
[50] Bernard Friedman,et al. Multiple hospitalizations for patients with diabetes. , 2003, Diabetes care.
[51] H. Nawaz,et al. Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. , 2003, Diabetes care.
[52] Emanuela Falcinelli,et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. , 2003, Journal of the American College of Cardiology.
[53] M. Cakir,et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2003, The Journal of clinical endocrinology and metabolism.
[54] Miet Schetz,et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.
[55] R. Marfella,et al. Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.
[56] R. Marfella,et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. , 2002, Diabetes.
[57] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[58] K. Taylor,et al. Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting. , 2001, Diabetes care.
[59] B. Tavernier,et al. Perioperative care of diabetic patients. , 2001, European journal of anaesthesiology.
[60] L. Title,et al. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. , 2000, Journal of the American College of Cardiology.
[61] L. Rydén,et al. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. , 1999, Diabetes care.
[62] K. Claffey,et al. TNF-α impairs insulin signaling and insulin stimulation of glucose uptake in C2C12muscle cells. , 1999, American journal of physiology. Endocrinology and metabolism.
[63] K. Jablonski,et al. Unrecognized Diabetes Among Hospitalized Patients , 1998, Diabetes Care.
[64] A. Baron,et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. , 1997, The Journal of clinical investigation.
[65] B. Genetet,et al. Impaired Leucocyte Functions in Diabetic Patients , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[66] J Herlitz,et al. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. , 1996, European heart journal.
[67] C. Lang,et al. ENDOTOXIN‐INDUCED ALTERATIONS IN INSULIN‐STIMULATED PHOSPHORYLATION OF INSULIN RECEPTOR, IRS‐1, AND MAP KINASE IN SKELETAL MUSCLE , 1996, Shock.
[68] K. Petersen,et al. Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.
[69] L. Opie,et al. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias , 1994, The Lancet.
[70] M. Press,et al. Growth hormone and metabolism. , 1988, Diabetes/metabolism reviews.
[71] R. Rizza,et al. Effects of glucocorticoids on carbohydrate metabolism. , 1988, Diabetes/metabolism reviews.
[72] J. Yudkin,et al. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. , 1986, British medical journal.
[73] T. Chan. The permissive effects of glucocorticoid on hepatic gluconeogenesis. Glucagon stimulation of glucose-suppressed gluconeogenesis and inhibition of 6-phosphofructo-1-kinase in hepatocytes from fasted rats. , 1984, The Journal of biological chemistry.
[74] J. Dundee,et al. Plasma Cortisol and blood sugar following minor surgery under intravenous anaesthetics , 1974, Anaesthesia.
[75] G. F. Sutton. Hospitalization in the last year of life. United States. 1961. , 1965, Vital and health statistics. Ser. 1, Programs and collection procedures.
[76] S. Trzeciak. Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring , 2010 .
[77] Jiaquan Xu,et al. Deaths: final data for 2007. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[78] J. Krinsley. Blood glucose control in critically ill patients: the impact of diabetes. , 2009, Critical Care Medicine.
[79] L. Kennedy,et al. Utility of A1C for Diabetes Screening in the 1999-2004 NHANES Population , 2008 .
[80] L. Robinson,et al. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. , 2004, AACN clinical issues.
[81] I. Hirsch,et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[82] A. Malhotra,et al. Stress-induced hyperglycemia. , 2001, Critical care clinics.
[83] G. Pellegrini,et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat , 2001, Acta Diabetologica.
[84] M. Harris. Medical Care for Patients with Diabetes: Epidemiologic Aspects , 1996, Annals of Internal Medicine.
[85] C H Lang,et al. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. , 1992, Endocrinology.
[86] Sönksen Ph. Home monitoring of blood glucose by diabetic patients. , 1980 .